All Cancer Microbiology articles – Page 2
-
NewsDisease-causing pathogen rewires gut metabolism to secure nutrients for growth
Enterotoxigenic Bacteroides fragilis (ETBF), which causes diarrhea and has been implicated in colitis and colorectal cancer, uses a toxin it produces to reprogram intestinal cell metabolism and generate conditions that support its growth.
-
NewsCervical cancer: A growing gap between high- and low-income countries
While high-income countries could eliminate cervical cancer by 2048 through human papillomavirus (HPV) vaccination and screening, the gap with lower-income countries is widening.
-
NewsScientists source anti-cancer treatment in bacteria
Researchers have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. The therapy is made from a fragment of a bacterial protein, a peptide called aurB. In cancer tumors in the animal models, aurB prevented energy production in the tumor cells’ mitochondria, essentially cutting off the tumor’s fuel.
-
NewsLifestyle, diet, and clinical factors shape the gut microbiome in cancer patients
Lifestyle factors, such as physical activity and dietary modifications can beneficially modulate the gut microbiome of cancer patients - however their effects are often shaped by non-modifiable variables.
-
NewsScientists highlight the cost of delaying childhood vaccination
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life. A new study found that the longer the delay, the higher the cost in human life and health care.
-
NewsSecret to a healthy liver found in a young microbiome
Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study.
-
NewsResearchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
-
NewsPioneering virologist Bernard Roizman dies at 96
Bernard Roizman, ScD, world-leading expert on herpes simplex virus (HSV) and Joseph Regenstein Distinguished Service Professor Emeritus of Microbiology and Molecular Genetics and Cell Biology at The University of Chicago, died on April 13, 2026, at the age of 96.
-
NewsOral-gut axis points to salivary biomarkers for early gastric cancer detection
A recent study has identified distinct microbial “signatures” within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer (GC). Research shows how specific lactic acid-producing bacteria (LAB) migrate from the mouth to colonize the gastrointestinal tract.
-
NewsGut bacteria predict skin cancer recurrence, but only when matched for ‘microbial fingerprint’
The specific mix of bacteria living in a person’s gut can predict the chances that melanoma will recur after surgery and immunotherapy, which helps immune cells target cancer cells, according to a new study.
-
NewsSleep deprivation disrupts gut microbiota, worsening colorectal cancer outcomes
Researchers have found that the gut microbiota drives changes to the immune system caused by chronic sleep loss. These changes promote cancer progression, disrupt circadian rhythm and weaken the effectiveness of chemotherapy.
-
NewsThree European countries reach 90% HPV vaccination target as Europe steps up action on cancer prevention
All EU/EEA countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s’ cancer prevention efforts. Iceland, Portugal and Norway have reached the target of 90% HPV vaccination coverage among girls by the age of 15.
-
NewsStudy reveals genome-wide host–virus genetic interactions in cancer risk
Researchers report a major advance in understanding how interactions between human and viral genomes shape disease risk. They found that variations in the Epstein–Barr virus, together with a specific immune-related gene (HLA-A*11:01), strongly influence the risk of nasopharyngeal cancer.
-
NewsCat viruses offer window into human oncogenesis
Cats are not just beloved companions; they are emerging as key “research partners” in unravelling viral cancer mechanisms. A new review explores how feline tumour viruses offer vital insights into human oncology and viral carcinogenesis from a comparative oncology perspective.
-
NewsMethod for amplifying the full genome of human papillomavirus 16 uses overlapping extension polymerase chain reaction
Human papillomavirus (HPV) is a double-stranded circular DNA virus with a genome of approximately 7–8 kb. A new study aims to establish an overlapping extension polymerase chain reaction method for the amplification of the entire genome of HPV16.
-
NewsImmunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents compared with young women
Based on new findings, the National Medical Products Administration of China has approved a two-dose immunization schedule for the domestically produced 9-valent HPV vaccine in girls aged 9 to 17 years.
-
NewsResearchers to test a gut microbiome intervention as part of a cancer therapy regimen
A phase III clinical trial will test a gut microbiome intervention as part of a kidney cancer therapy regimen. The investigational agent is a once-daily capsule requiring no refrigeration or special handling.
-
NewsTurmeric/ginger extract shows multiple benefits for bone implants
An extract of turmeric and ginger helps bone implants bond strongly while killing bacteria and cancer cells, according to new research with implications for millions of patients with joint replacements and bone cancer.
-
NewsA new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments
Researchers have created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.
-
NewsShiitake-derived β-glucan inhibits human cervical cancer progression through DMBT1
A team of researchers investigated the molecular mechanism underlying the anti-cervical cancer activity of Lentinus edodes-derived β-glucan (LNT) and, for the first time, identified DMBT1 as a key target.